pharmaphorum’s latest Deep Dive issue is dedicated to oncology and includes some interesting highlights from American Society of Clinical Oncology (ASCO), thoughts from Debiopharm Innovation Fund’s Tanja Dowe on enabling healthcare’s digital future, and digital health innovation expert, Kristin Milburn, Managing Director at Healthware Labs, explores how COVID has acted as a digital adoption accelerant and the potential it created for startups to grow their businesses as well as the changes unfolding in the emerging DTx space.
Digital health has come a long way in the past decade – and Kristin Milburn says that the sector could now be about to enter its most exciting period yet.
Through her role as managing director of innovation consultancy Healthware Labs, Milburn has seen first-hand how digital health has evolved. In particular she points to a move beyond tools that surround or support medications – such as adherence solutions – or those that take proven analogue programmes, such as CBT or physical therapy solutions, and digitise them for wider availability.
Fill in the form to request your copy of the interview